The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 16 Jun 2005
doi: 10.1242/jcs.02423
Research Article
Identification of the cyclic-nucleotide-binding domain as a conserved determinant of ion-channel cell-surface localization
Armin Akhavan,
Roxana Atanasiu,
Tomohiro Noguchi,
Wei Han,
Natasha Holder,
and
Alvin Shrier*
* Author for correspondence (e-mail: alvin.shrier{at}mcgill.ca)
Mutations of a putative cyclic-nucleotide-binding domain (CNBD) can disrupt the function of the hyperpolarization-activated cyclic-nucleotide-gated channel (HCN2) and the human ether-a-go-go-related gene potassium channel (HERG). Loss of function caused by C-terminal truncation, which includes all or part of the CNBD in HCN and HERG, has been related to abnormal channel trafficking. Similar defects have been reported for several of the missense mutations of HERG associated with long QT syndrome type 2 (LQT2). Thus, we postulate that normal processing of these channels depends upon the presence of the CNBD. Here, we show that removal of the entire CNBD prevents Golgi transit, surface localization and function of HERG channel tetramers. This is also true when any of the structural motifs of the CNBD is deleted, suggesting that deletion of any highly conserved region along the entire length of the CNBD can disrupt channel trafficking. Furthermore, we demonstrate that defective trafficking is a consequence of all LQT2 mutations in the CNBD, including two mutations not previously assessed and two others for which there are conflicting results in the literature. The trafficking sensitivity of the CNBD might be of general significance for other ion channels because complete deletion of the CNBD or mutations at highly conserved residues within the CNBD of the related ERG3 channel and HCN2 also prevent Golgi transit. These results broadly implicate the CNBD in ion-channel trafficking that accounts for the commonly observed loss of function associated with CNBD mutants and provides a rationale for distinct genetic disorders.
This article has been cited by other articles:
|
|
|
|
 
H. Nazzari, D. Angoli, S. S. Chow, G. Whitaker, L. Leclair, E. McDonald, V. Macri, K. Zahynacz, V. Walker, and E. A. Accili
Regulation of cell surface expression of functional pacemaker channels by a motif in the B-helix of the cyclic nucleotide-binding domain
Am J Physiol Cell Physiol,
September 1, 2008;
295(3):
C642 - C652.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Guasti, O. Crociani, E. Redaelli, S. Pillozzi, S. Polvani, M. Masselli, T. Mello, A. Galli, A. Amedei, R. S. Wymore, et al.
Identification of a Posttranslational Mechanism for the Regulation of hERG1 K+ Channel Expression and hERG1 Current Density in Tumor Cells
Mol. Cell. Biol.,
August 15, 2008;
28(16):
5043 - 5060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Moss and I. Goldenberg
Importance of Knowing the Genotype and the Specific Mutation When Managing Patients With Long-QT Syndrome
Circ Arrhythmia Electrophysiol,
August 1, 2008;
1(3):
219 - 226.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. F. Steele, J. Eldstrom, and D. Fedida
Mechanisms of cardiac potassium channel trafficking
J. Physiol.,
July 1, 2007;
582(1):
17 - 26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mikosch, A. C. Hurst, B. Hertel, and U. Homann
Diacidic Motif Is Required for Efficient Transport of the K+ Channel KAT1 to the Plasma Membrane
Plant Physiology,
November 1, 2006;
142(3):
923 - 930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-u. Choe, E. Schulze-Bahr, A. Neu, J. Xu, Z. I. Zhu, K. Sauter, R. Bahring, S. Priori, P. Guicheney, G. Monnig, et al.
C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3{epsilon}
Hum. Mol. Genet.,
October 1, 2006;
15(19):
2888 - 2902.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
